M-092

N/A

Report date: 2025/03/18 13:50:30

Base Information

Drug NameM-092
Drug Alias NameM-092AAV-TPP1-S1S3
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsNeuronal ceroid lipofuscinosis type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesM6P Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesM6P Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNeuronal ceroid lipofuscinosis type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A